Vontier VNT
Vontier Q2 FY26: revenue $756.7M, down 2%; diluted EPS $0.20
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001628280-26-054180
Key figures from this report
These are the numbers Vontier reported for Q2 FY26, the quarter ended Jul 3, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$756.7M−2% from $773.5M in Q2 FY2510-Q income statement, on EDGAR
- Diluted EPS$0.20−68% from $0.62 in Q2 FY2510-Q income statement, on EDGAR
- Cash and cash equivalents$265.8M−27% from $364.2M in Q2 FY2510-Q balance sheet, on EDGAR
- Cash from operations$116.3M+16% from $100.0M in Q2 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 3824 and related industry codes: the same peer list as the financial tables.
- Cognex CGNX public float $5.3B, Jun 27, 2025
- Itron ITRI public float $5.9B, Jun 30, 2025
- Bio-Rad Laboratories BIO
- Mirion Technologies MIR public float $4.8B, Jun 30, 2025
- MKS MKSI public float $6.7B, Jun 30, 2025
